Credo R B, Curtis C G, Lorand L
Proc Natl Acad Sci U S A. 1978 Sep;75(9):4234-7. doi: 10.1073/pnas.75.9.4234.
Fibrinogen displays a regulation of considerable physiological significance by lowering the Ca2+ requirement for the conversion of the fibrin-stabilizing factor (Factor XIII) zymogen to the range of concentrations of this ion found in plasma. Fibrinogen modulates both Ca2+-dependent steps in the complex process of zymogen activation, involving the heterologous dissociation of subunits of the thrombin-modified zymogen (Factor XIII') species : formula: (see text) and the unmasking of iodoacetamide titratable sites during generation of transamidating activity : formula: (see text). It is interesting that a thrombin-independent pathway of zymogen activation : formula: (see text), which we found to operate at Ca2+ concentrations above 50 mM, is not affected by the presence of fibrinogen. Regulation by fibrinogen thus appears to be specific for controlling only the physiological pathway of zymogen conversion.
纤维蛋白原通过将纤维蛋白稳定因子(因子 XIII)酶原转化所需的 Ca2+ 浓度降低到血浆中该离子的浓度范围,显示出具有相当生理意义的调节作用。纤维蛋白原调节酶原激活复杂过程中两个依赖 Ca2+ 的步骤,这涉及凝血酶修饰的酶原(因子 XIII')亚基的异源解离:公式:(见正文)以及转酰胺活性产生过程中碘乙酰胺可滴定位点的暴露:公式:(见正文)。有趣的是,我们发现一种不依赖凝血酶的酶原激活途径:公式:(见正文),在 Ca2+ 浓度高于 50 mM 时起作用,不受纤维蛋白原存在的影响。因此,纤维蛋白原的调节似乎仅对控制酶原转化的生理途径具有特异性。